micro-community-banner
 
  • Saved

1mo
Restoration of skeletal muscle function via mesenchymal stem cells: mechanistic insights and therapeutic advances in myasthenia gravis - PubMed

Restoration of skeletal muscle function via mesenchymal stem cells: mechanistic insights and therapeutic advances in myasthenia gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41063964/

Mesenchymal stem cells (MSCs) have demonstrated distinct advantages in skeletal muscle repair owing to their self-renewal capacity, multidirectional differentiation potential, and immunomodulatory functions. As a critical regulator of skeletal muscle...

This review explores mesenchymal stem cells’ roles in skeletal muscle repair and myasthenia gravis therapy through immunomodulation, neuroprotection, and regeneration, highlighting translational challenges and optimization strategies for neuromuscular disease treatment.

  • Saved

1mo

Fun Fact! Structured psychotherapy—not medication—is the cornerstone of effective BPD treatment. Evidence-based therapies like DBT, MBT, or TFP are tailored to core BPD features like emotional instability, identity confusion, and impulsivity.

Did you know that medication is only recommended as a supportive tool for specific symptoms, not as the main treatment for BPD?

NCCN Guidelines

Did you know that medication is only recommended as a supportive tool for specific symptoms, not as the main treatment for BPD?

  • Saved

1mo
Background Image DesktopBackground Image Mobile

Oral methadone and buprenorphine remain gold standards for OUD. New depot buprenorphine, retarded morphine, and diacetylmorphine offer alternatives, especially for refractory patients. Depot options improve adherence, supporting tailored, long-term management.

See how OUD treatment is evolving

  • Saved

1mo
infographic infographic 
  • Saved

1mo
Immunoglobulin National Society National Conference

The Immunoglobulin National Society (IgNS) will hold its 14th National Conference from Oct. 16 to 19 in Dallas. The conference is the premier annual event for clinicians, business professionals, and industry leaders in the immunoglobulin (Ig) therapy and biologics space. Attendees will learn about the latest advancements in patient care and make connections with colleagues.

Click to access highlights that are in the upcoming conference.